IVRN — Innoveren Scientific Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $5.58m
- $0.45m
Annual balance sheet for Innoveren Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-Q | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.07 | 1.42 | 1.64 | 0.095 | 0 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.02 | 0.041 | 0.022 | 0.057 | 0.029 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.15 | 2.28 | 1.76 | 0.197 | 0.084 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.267 | 0.958 | 0.418 | 0.038 | 0.02 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.455 | 3.27 | 2.2 | 0.321 | 0.137 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.19 | 5.77 | 2.89 | 4.92 | 7.48 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.15 | 12.4 | 2.88 | 4.98 | 9.49 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -5.7 | -9.09 | -0.678 | -4.66 | -9.36 |
| Total Liabilities & Shareholders' Equity | 0.455 | 3.27 | 2.2 | 0.321 | 0.137 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |